Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL825P (RNA, 7SL, cytoplasmic 825, pseudogene) is a genomic locus annotated in humans as a processed pseudogene derived from the 7SL RNA family[6][4][3]. The parent molecule, 7SL RNA, is an integral non-coding RNA within the signal recognition particle (SRP), playing an essential role in protein targeting to membranes via co-translational mechanisms[1][5]. However, RN7SL825P itself is a truncated, non-functional copy of 7SL RNA, produced from reverse transcription and erroneous integration into the genome[3]. Like other processed pseudogenes, it lacks regulatory elements and is not expressed as a functional gene product[2][3]. While pseudogenes occasionally participate in regulatory RNA networks, there is no evidence for RN7SL825P functioning as a biomarker, disease gene, or therapeutic target, nor for any clinical or pharmaceutical relevance at this time[6][7][4]. If structured information is needed for database curation, these entries should indicate its status as a pseudogene, and not as a classical receptor, enzyme, transporter, or therapeutic target.
Not applicable; no drugs are described to target RN7SL825P
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 825, pseudogene (RN7SL825P).